JIB-04, a Pan-Inhibitor of Histone Demethylases, Targets Histone-Lysine-Demethylase-Dependent AKT Pathway, Leading to Cell Cycle Arrest and Inhibition of Cancer Stem-Like Cell Properties in Hepatocellular Carcinoma Cells

JIB-04, a pan-histone lysine demethylase (KDM) inhibitor, targets drug-resistant cells, along with colorectal cancer stem cells (CSCs), which are crucial for cancer recurrence and metastasis. Despite the advances in CSC biology, the effect of JIB-04 on liver CSCs (LCSCs) and the malignancy of hepato...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jina, Kim, Ji-Soo, Cho, Hye-In, Jo, So-Ra, Jang, Yeun-Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322929/
https://www.ncbi.nlm.nih.gov/pubmed/35887001
http://dx.doi.org/10.3390/ijms23147657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322929/
https://www.ncbi.nlm.nih.gov/pubmed/35887001
http://dx.doi.org/10.3390/ijms23147657

Ejemplares similares